Serum markers in breast cancer management
- 1 December 1992
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 1 (4) , 173-178
- https://doi.org/10.1016/0960-9776(92)90120-q
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3European Journal of Cancer and Clinical Oncology, 1991
- Philosophy of Measurement by Means of ImmunoassaysScandinavian Journal of Clinical and Laboratory Investigation, 1991
- CA15.3, MCA, CAM26, CAM29 Are Members of a Polymorphic Family of Mucin-Like GlycoproteinsTumor Biology, 1991
- Comparison of breast cancer mucin (BCM) and CA 15-3 in human breast cancerBreast Cancer Research and Treatment, 1990
- CA-15.3, TPA and MCA as markers for breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Cancers of the breast, endometrium and ovary: Geographic correlationsEuropean Journal of Cancer and Clinical Oncology, 1989
- A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancerCancer, 1989
- Markers in breast cancer: Does CEA add to the detection by CA 15.3?Breast Cancer Research and Treatment, 1988
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978
- Multivariate biochemical indicators of breast cancer: An evaluation of their potential in routine practicePublished by Elsevier ,1978